Preclinical Considerations: Testing Regulated Wound Healing Devices
In today’s rapidly advancing medical device landscape, wound healing stands out as a top priority for innovation. Medical device manufacturers face many challenges in their product development and regulatory path for demonstrating the safety and effectiveness of new therapies in preclinical studies. In this webinar, NAMSA experts will offer valuable insights into regulatory considerations and testing strategies. Our speakers will provide a comprehensive overview of FDA and EU regulatory requirements, delve into testing strategies and share “tips and tricks” for navigating unconventional scenarios and novel devices.
- Regulatory Expertise: Gain in-depth knowledge of FDA and EU regulatory requirements to ensure your preclinical research and wound healing devices meet the current standards
- Testing Strategy Excellence: Discover essential testing strategies to optimize your preclinical studies for different wound healing therapies
- Navigating the Unconventional: Learn about options to consider for testing approaches when products are novel and DeNovo
*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.
NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.